Linden Advisors LP Acquires Shares of 600,000 Translational Development Acquisition Corp. (NASDAQ:TDACU)

Linden Advisors LP acquired a new position in Translational Development Acquisition Corp. (NASDAQ:TDACUFree Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 600,000 shares of the company’s stock, valued at approximately $11,064,000.

Several other institutional investors have also recently made changes to their positions in the business. Tuttle Capital Management LLC purchased a new stake in Translational Development Acquisition in the fourth quarter valued at $461,000. Parallax Volatility Advisers L.P. purchased a new position in Translational Development Acquisition in the fourth quarter valued at $929,000. Wealthspring Capital LLC acquired a new position in shares of Translational Development Acquisition in the fourth quarter worth about $1,095,000. Yakira Capital Management Inc. purchased a new stake in shares of Translational Development Acquisition during the 4th quarter worth about $1,106,000. Finally, Warberg Asset Management LLC acquired a new stake in shares of Translational Development Acquisition during the 4th quarter valued at about $1,373,000.

Translational Development Acquisition Stock Down 0.4%

Shares of Translational Development Acquisition stock opened at $10.26 on Monday. Translational Development Acquisition Corp. has a twelve month low of $10.00 and a twelve month high of $10.30. The company has a 50-day simple moving average of $10.18.

Translational Development Acquisition Profile

(Free Report)

Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.

See Also

Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACUFree Report).

Institutional Ownership by Quarter for Translational Development Acquisition (NASDAQ:TDACU)

Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.